One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...

Novavax's financial position improved significantly with a $570 million cash infusion from Sanofi. Find out why I remain ...

There are currently no recommendations for anyone to be vaccinated against bird flu and federal health officials note this is ...

AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...

Among the large drugmakers, Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer are worth retaining in one’s portfolio.

One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years ...

As more farm workers get sick with avian influenza, the US federal government is putting $72 million toward strengthening its ...

The NHS is offering autumn Covid boosters to the most vulnerable in October. Many pharmacies also now sell the Covid jab ...

Per the deal terms, Sanofi took a minority stake in NVAX (a $70 million equity investment), will gain rights to co-market Novavax’s COVID-19 vaccine globally, and will have the sole license to ...

Sanofi, MSD and Janssen. COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it’s estimated COVID shots have saved more than 1.4 million lives in the Wor ...